136
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma

, , , , , , ORCID Icon & show all
Pages 1765-1777 | Published online: 29 Apr 2021

References

  • VosT, AbajobirAA, AbateKHet al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.28919117
  • BatemanED, HurdSS, BarnesPJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178. doi:10.1183/09031936.0013870718166595
  • GodsonC, PhimisterEG. Balancing the effect of leukotrienes in asthma. N Engl J Med. 2020;382(15):1472–1475. doi:10.1056/NEJMcibr200011832268033
  • ChettaA, ZaniniA, ForesiA, et al. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy. 2005;35(11):1437–1442. doi:10.1111/j.1365-2222.2005.02360.x16297139
  • BeasleyR, HarperJ, BirdG, MaijersI, WeatherallM, PavordID. Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology. Am J Respir Crit Care Med. 2019;199(12):1471–1477. doi:10.1164/rccm.201810-1868CI30645143
  • GuptaRP, MukherjeeM, SheikhA, StrachanDP. Persistent variations in national asthma mortality. Hospital Admissions and Prevalence by Socioeconomic Status and Region in England, Thorax. 2018;73(8):706–712.30006496
  • MarmotM. Inequalities in asthma mortality: a specific case of a general issue of health inequalities. Thorax. 2018;73(8):704–705. doi:10.1136/thoraxjnl-2018-21157330006495
  • HolmM, OmenaasE, GíslasonT, et al. Remission of asthma: a prospective longitudinal study from northern Europe (RHINE study). Eur Respir J. 2007;30(1):62–65. doi:10.1183/09031936.0012170517360725
  • DennerDR, SangwanN, BeckerJB, et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol. 2016;137(5):1398–1405.e3. doi:10.1016/j.jaci.2015.10.01726627545
  • DeykinA, LazarusSC, FahyJV, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol. 2005;115(4):720–727. doi:10.1016/j.jaci.2004.12.112915805990
  • GauvreauGM, JordanaM, WatsonRM, CockroftDW, O’ByrnePM. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med. 1997;156(6):1738–1745. doi:10.1164/ajrccm.156.6.96-080429412549
  • SearsMR, TaylorDR, PrintCG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990;336(8728):1391–1396. doi:10.1016/0140-6736(90)93098-A1978871
  • SearsMR. Worldwide trends in asthma mortality. Bull Int Union Tuberc Lung Dis. 1991;66(2–3):79–83.1684522
  • PearceN. The use of beta agonists and the risk of death and near death from asthma. J Clin Epidemiol. 2009;62(6):582–587. doi:10.1016/j.jclinepi.2009.01.00419422997
  • HuiD, YonghongW, JianY, et al. Prescriptions from traditional Chinese medicine compared with salbutamol and montelukast for the treatment of pediatric asthma: a randomized controlled trial. J Tradit Chin Med. 2017;37(4):522–529. doi:10.1016/S0254-6272(17)30159-032188211
  • DuH, WangY, ShiY, YuJ, SunW, ZhangY. Effect of traditional Chinese medicine on inflammatory mediators in pediatric asthma. Mediators Inflamm. 2016;2016:1–6. doi:10.1155/2016/5143703
  • WojcikowskiK, GobeG. Animal studies on medicinal herbs: predictability, dose conversion and potential value. Phytother Res. 2014;28(1):22–27. doi:10.1002/ptr.496623553964
  • NialsAT, UddinS. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech. 2008;1(4–5):213–220. doi:10.1242/dmm.00032319093027
  • PatelBV, WilsonMR, TakataM. Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J. 2012;39(5):1162–1170. doi:10.1183/09031936.0009391122005920
  • RuJ, LiP, WangJ, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13. doi:10.1186/1758-2946-6-1324735618
  • NiuWH, WuF, CaoWY, WuZG, ChaoYC, LiangC. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6. Biosci Rep. 2021;41(1). doi:10.1042/BSR20202583
  • XuX, ZhangW, HuangC, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13(6):6964–6982. doi:10.3390/ijms1306696422837674
  • WanY, XuL, LiuZ, et al. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms. BMC Complement Altern Med. 2019;19(1):158. doi:10.1186/s12906-019-2580-y31272505
  • ChiZ, WeiG, Ling-LingS, Han-RuiC, Li-ZhuL. Network pharmacology-based analysis of the mechanism of action of the Herb Pair Chai Hu-Bai Shao. Digital Chin Med. 2019;2(4):227–236. doi:10.1016/j.dcmed.2020.01.004
  • YamanishiY, KoteraM, KanehisaM, GotoS. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics. 2010;26(12):i246–i254. doi:10.1093/bioinformatics/btq17620529913
  • PeiT, ZhengC, HuangC, et al. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. J Ethnopharmacol. 2016;190:272–287. doi:10.1016/j.jep.2016.06.00127265513
  • YuM, SongX, YangW, LiZ, MaX, HaoC. Identify the key active ingredients and pharmacological mechanisms of compound XiongShao capsule in treating diabetic peripheral neuropathy by network pharmacology approach. Evid Based Complement Alternat Med. 2019;2019:580–1591. doi:10.1155/2019/5801591
  • FranceschiniA, SzklarczykD, FrankildS, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808–D815. doi:10.1093/nar/gks109423203871
  • NguyenHH, ParkJ, KangS, KimM. Surface plasmon resonance: a versatile technique for biosensor applications. Sensors. 2015;15(5):10481–10510. doi:10.3390/s15051048125951336
  • ParkSH, KangJS, YoonYD, et al. Glabridin inhibits lipopolysaccharide-induced activation of a microglial cell line, BV-2, by blocking NF-kappaB and AP-1. Phytother Res. 2010;24(Suppl 1):S29–S34. doi:10.1002/ptr.287219455572
  • KangJS, YoonYD, ChoIJ, et al. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. J Pharmacol Exp Ther. 2005;312(3):1187–1194. doi:10.1124/jpet.104.07710715537821
  • AdamsM, PacherT, GregerH, BauerR. Inhibition of leukotriene biosynthesis by stilbenoids from Stemona species. J Nat Prod. 2005;68(1):83–85. doi:10.1021/np049704315679323
  • ChandrasekaranCV, DeepakHB, ThiyagarajanP, et al. Dual inhibitory effect of Glycyrrhiza glabra (GutGard™) on COX and LOX products. Phytomedicine. 2011;18(4):278–284. doi:10.1016/j.phymed.2010.08.00120864324
  • KimJY, KangJS, KimHM, et al. Inhibition of bone marrow-derived dendritic cell maturation by glabridin. Int Immunopharmacol. 2010;10(10):1185–1193. doi:10.1016/j.intimp.2010.06.02520633530
  • TamirS, EizenbergM, SomjenD, et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 2000;60(20):5704–5709.11059763
  • LvX, XuZ, XuG, et al. Investigation of the active components and mechanisms of Schisandra chinensis in the treatment of asthma based on a network pharmacology approach and experimental validation. Food Funct. 2020;11(4):3032–3042. doi:10.1039/D0FO00087F32186565
  • HuangXF, ChengWB, JiangY, et al. A network pharmacology-based strategy for predicting anti-inflammatory targets of ephedra in treating asthma. Int Immunopharmacol. 2020;83:106423. doi:10.1016/j.intimp.2020.10642332279042
  • DongZJ, GuoX, ChenLJ, HanYF, JinGZ. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Life Sci. 1997;61(4):465–472. doi:10.1016/S0024-3205(97)00404-99244373
  • ZouLL, LiuJ, JinGZ. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats. Biochem Pharmacol. 1997;54(2):233–240. doi:10.1016/S0006-2952(97)00153-69271327
  • HaoJR, SunN, LeiL, et al. L-Stepholidine rescues memory deficit and synaptic plasticity in models of alzheimer’s disease via activating dopamine D1 receptor/PKA signaling pathway. Cell Death Dis. 2015;6(11):e1965. doi:10.1038/cddis.2015.31526539912
  • ShinagawaK, MartinJA, PloplisVA, CastellinoFJ. Coagulation factor Xa modulates airway remodeling in a murine model of asthma. Am J Respir Crit Care Med. 2007;175(2):136–143. doi:10.1164/rccm.200608-1097OC17082493
  • JosephK, TholanikunnelBG, KaplanAP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A. 2002;99(2):896–900. doi:10.1073/pnas.02262689911792853